PDL BIOPHARMA INC's ticker is and the CUSIP is 69329YAC8. A total of 17 filers reported holding PDL BIOPHARMA INC in Q4 2014. The put-call ratio across all filers is - and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2014 | $17,779,000 | +3.7% | 13,446,000 | 0.0% | 0.85% | -14.8% |
| Q3 2014 | $17,142,000 | -20.4% | 13,446,000 | 0.0% | 1.00% | -26.6% |
| Q2 2014 | $21,531,000 | +23.7% | 13,446,000 | +5.5% | 1.36% | +51.1% |
| Q1 2014 | $17,400,000 | -26.3% | 12,751,000 | -26.5% | 0.90% | -12.9% |
| Q4 2013 | $23,595,000 | +6.8% | 17,350,000 | 0.0% | 1.04% | +4.7% |
| Q3 2013 | $22,103,000 | +2.8% | 17,350,000 | 0.0% | 0.99% | +1.4% |
| Q2 2013 | $21,507,000 | – | 17,350,000 | – | 0.98% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| LINDEN ADVISORS LP | 25,000,000 | $33,937,000 | 5.99% |
| WHITEBOX ADVISORS LLC | 26,374,000 | $35,687,000 | 1.57% |
| Castle Creek Arbitrage, LLC | 17,350,000 | $23,595,000 | 1.04% |
| GUARDIAN LIFE INSURANCE CO OF AMERICA | 4,598,000 | $6,886,000 | 0.63% |
| WOLVERINE ASSET MANAGEMENT LLC | 15,690,000 | $21,206,000 | 0.42% |
| CSS LLC/IL | 3,083,000 | $4,094,000 | 0.20% |
| HIGHBRIDGE CAPITAL MANAGEMENT LLC | 8,750,000 | $11,840,000 | 0.14% |
| PALISADE CAPITAL MANAGEMENT, LP | 3,500,000 | $4,751,000 | 0.12% |
| AMUNDI ASSET MANAGEMENT US, INC. | 11,810,000 | $15,980,000 | 0.06% |
| LAZARD ASSET MANAGEMENT LLC | 16,957,000 | $22,944,000 | 0.05% |